Description
A novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Investigated for its synergistic metabolic effects in preclinical models of obesity and glucose homeostasis.
€ 65.00
This product is intended for laboratory research use only. It is not intended for human or veterinary use.
Get your order delivered quickly with full tracking.
Verified purity and consistency for reliable research results.
A novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Investigated for its synergistic metabolic effects in preclinical models of obesity and glucose homeostasis.
Reviews
There are no reviews yet.